ICU MEDICAL INC/DE 10-Q

Item 3. Quantitative and Qualitative Disclosures about Market Risk Interest Rate Risk If we were to incur borrowings under our Credit Facility, we would face market risk stemming from changes in interest rates. Foreign Exchange Risk We have foreign currency exchange risk related to foreign-denominated cash, accounts receivable and accounts payable and accrued liabilities. In our European operations, our net Euro asset position at September 30, 2020 was approximately €51.2 million. A 10% change in the conversion of the Euro to the U.S. dollar for our cash, accounts receivable, accounts payable and accrued liabilities from the September 30, 2020 spot rate would impact our consolidated amounts on these balance sheet items by approximately $6.0 million, or 0.8% of these consolidated net assets. We expect that in the future, with the growth of our European distribution operations, net Euro denominated instruments will continue to increase. We currently do not hedge our Euro foreign currency exposures. 42 Table of Contents We have manufacturing facilities and conduct business transactions denominated in the Mexican Peso. We hedge a portion of our manufacturing spend, which reduces our exposure to the foreign currency exchange risk related to the Mexican Peso (see Note 7: Derivatives and Hedging to the condensed consolidated financial statements in Part I, Item 1 of this Form 10-Q).